DrugPatentWatch Database Preview

Details for Patent: 8,428,708

« Back to Dashboard

Which drugs does patent 8,428,708 protect, and when does it expire?

Patent 8,428,708 protects IONSYS and is included in one NDA.

This patent has seventy-eight patent family members in eighteen countries.

Summary for Patent: 8,428,708

Title:	Self-test for analgesic product
Abstract:	Electrotransport drug delivery devices, system and methods of using configured to determine if a current is present between the anode and cathode when drug is not intended to be delivered by the device. These devices/systems may include an off-current module to determine that any current (e.g., which may be inferred by measuring potential difference between the anode and cathode of the device) flowing between the anode and cathode is below a threshold value when the device is not supposed to be delivering drug, thereby preventing unintended delivery of drug and/or alerting a user that unintended delivery of drug may occur.
Inventor(s):	White; Bradley E. (Mason, OH), Lemke; John (Pleasanton, CA), Hayter; Paul (Mountain View, CA), Chen; Corinna X. (Oakland, CA), Read; Brian W. (Brier, WA), Dougherty; Jason E. (Seattle, WA)
Assignee:	Incline Therapeutics, Inc. (Redwood City, CA) Alza Corporation (Vacaville, CA)
Application Number:	13/476,960
Patent Claim Types: see list of patent claims	Use; Delivery; Device;

Drugs Protected by US Patent 8,428,708

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Patent Submitted
The Medicines Co	IONSYS	fentanyl hydrochloride	SYSTEM;IONTOPHORESIS, TRANSDERMAL	021338-001	May 22, 2006		RX	Yes	Yes						METHOD FOR IONTOPHORETIC TRANSDERMAL DELIVERY OF FENTANYL HYDROCHLORIDE

Non-Orange Book US Patents Family Members for Patent 8,428,708

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No.	Title	Estimated Patent Expiration
8,781,571	Switch validation circuit and method
9,095,706	Self-test for analgesic product
9,364,656	Method of storing an electrotransport drug delivery device
8,301,238	Two-part electrotransport device

International Patents Family Members for US Patent 8,428,708

Country	Document Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2012238095
Australia	2012238096
Australia	2013266914
Australia	2013274873